What was the most commonly reported adverse reaction considered related to fexofenadine in clinical trials involving children aged 6–11 years?

Headache was the most commonly reported adverse reaction investigators considered at least possibly related to fexofenadine in controlled trials involving children aged 6–11 years, occurring in 1.0% of both the fexofenadine 30 mg and placebo groups.